Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study

Murat Emre, Werner Poewe, Peter Paul De Deyn, Paolo Barone, Jaime Kulisevsky, Emmanuelle Pourcher, Teus Van Laar, Alexander Storch, Federico Micheli, David Burn, Frank Durif, Rajesh Pahwa, Francesca Callegari, Nadia Tenenbaum, Christine Strohmaier

Producció científica: Contribució a una revistaArticleRecercaAvaluat per experts

58 Cites (Scopus)

Fingerprint

Navegar pels temes de recerca de 'Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study'. Junts formen un fingerprint únic.

Pharmacology, Toxicology and Pharmaceutical Science